- Report
- May 2023
- 83 Pages
Global
From €3500EUR$4,209USD£3,097GBP
- Report
- September 2026
China
From €3554EUR$3,990USD£3,039GBP
- Report
- September 2026
United Kingdom
From €3554EUR$3,990USD£3,039GBP
- Report
- September 2026
- 70 Pages
China
From €1202EUR$1,350USD£1,028GBP
- Report
- September 2026
- 70 Pages
Mexico
From €1202EUR$1,350USD£1,028GBP
- Report
- September 2026
United Kingdom
From €3554EUR$3,990USD£3,039GBP
- Report
- July 2025
- 155 Pages
Global
From €4142EUR$4,650USD£3,542GBP
From €890EUR$999USD£761GBP
- Report
- July 2025
- 210 Pages
Global
From €4320EUR$4,850USD£3,694GBP
- Report
- July 2025
- 140 Pages
Global
From €4320EUR$4,850USD£3,694GBP
- Report
- June 2025
- 150 Pages
Global
From €4320EUR$4,850USD£3,694GBP
- Report
- April 2025
- 107 Pages
China
From €1603EUR$1,800USD£1,371GBP
- Report
- April 2025
- 54 Pages
China
From €1603EUR$1,800USD£1,371GBP
- Report
- April 2025
- 132 Pages
Global
From €4320EUR$4,850USD£3,694GBP
- Report
- March 2025
- 150 Pages
Global
From €4320EUR$4,850USD£3,694GBP
- Report
- December 2024
- 199 Pages
United States
From €4944EUR$5,550USD£4,227GBP
- Report
- March 2024
- 132 Pages
Global
From €846EUR$950USD£724GBP
- Report
- March 2024
- 132 Pages
Global
From €846EUR$950USD£724GBP
- Report
- March 2024
- 132 Pages
Global
From €4142EUR$4,650USD£3,542GBP
- Report
- March 2024
- 250 Pages
Global
From €2182EUR$2,450USD£1,866GBP

The Gastrointestinal Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs used to treat diseases and disorders of the gastrointestinal tract. These drugs are used to treat conditions such as irritable bowel syndrome, Crohn's disease, ulcerative colitis, and gastroesophageal reflux disease. Commonly prescribed drugs include antacids, proton pump inhibitors, and H2 receptor antagonists.
The Gastrointestinal Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include Pfizer, GlaxoSmithKline, Merck & Co., AstraZeneca, and Novartis. These companies are constantly developing new drugs and treatments to meet the needs of patients. Show Less Read more